Back to Search
Start Over
Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2024 Jul; Vol. 65 (7), pp. 1024-1027. Date of Electronic Publication: 2024 Mar 21. - Publication Year :
- 2024
- Subjects :
- Humans
Child
Adolescent
Treatment Outcome
Female
Prognosis
Male
Child, Preschool
Fusion Proteins, bcr-abl genetics
Fusion Proteins, bcr-abl antagonists & inhibitors
Tyrosine Kinase Inhibitors
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive diagnosis
Protein Kinase Inhibitors therapeutic use
Protein Kinase Inhibitors adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 65
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38513148
- Full Text :
- https://doi.org/10.1080/10428194.2024.2331625